Shelly D Guyer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shelly D Guyer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shelly D Guyer. Shelly D Guyer is Chief Financial Officer in VERACYTE, INC. ($VCYT) and Director in NGM BIOPHARMACEUTICALS INC ($NGM) and Chief Financial Officer in Invitae Corp ($NVTA).
Latest Insider Trading Transactions of Shelly D Guyer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NVTA, NGM, VCYT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 42.90 | 6,265 | 268,772 | 228,309 | 234.6 K to 228.3 K (-2.67 %) |
| Mar 17 2021 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 42.90 | 11,882 | 509,745 | 234,574 | 246.5 K to 234.6 K (-4.82 %) |
| Mar 17 2021 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 24,936 | 0 | 246,456 | 221.5 K to 246.5 K (+11.26 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 47.91 | 300 | 14,373 | 224,520 | 224.8 K to 224.5 K (-0.13 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 47.91 | 300 | 14,373 | 224,520 | 224.8 K to 224.5 K (-0.13 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 47.17 | 1,187 | 55,991 | 224,820 | 226 K to 224.8 K (-0.53 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 47.17 | 1,187 | 55,991 | 224,820 | 226 K to 224.8 K (-0.53 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 46.20 | 1,513 | 69,901 | 226,007 | 227.5 K to 226 K (-0.66 %) |
| Nov 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 46.20 | 1,513 | 69,901 | 226,007 | 227.5 K to 226 K (-0.66 %) |
| Sep 14 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 33.87 | 631 | 21,370 | 227,520 | 228.2 K to 227.5 K (-0.28 %) |
| Sep 04 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 1,253 | 0 | 228,151 | 226.9 K to 228.2 K (+0.55 %) |
| Sep 04 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 1,253 | 0 | 228,151 | 226.9 K to 228.2 K (+0.55 %) |
| Aug 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 32.10 | 18,956 | 608,417 | 226,898 | 245.9 K to 226.9 K (-7.71 %) |
| Jul 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 33.65 | 1,300 | 43,746 | 245,854 | 247.2 K to 245.9 K (-0.53 %) |
| Jul 20 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 33.10 | 10,700 | 354,181 | 247,154 | 257.9 K to 247.2 K (-4.15 %) |
| Jun 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Option Exercise | A | 16.17 | 19,600 | 316,932 | 19,600 | |
| Jun 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 59,150 | 0 | 257,854 | 198.7 K to 257.9 K (+29.77 %) |
| Jun 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Option Exercise | A | 16.17 | 19,600 | 316,932 | 19,600 | |
| Jun 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 59,150 | 0 | 257,854 | 198.7 K to 257.9 K (+29.77 %) |
| May 22 2020 | NGM | NGM BIOPHARMACEUTI ... | Guyer Shelly D | Director | Option Exercise | A | 20.37 | 16,806 | 342,338 | 16,806 | |
| May 22 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 16.70 | 5,250 | 87,679 | 198,704 | 204 K to 198.7 K (-2.57 %) |
| Mar 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 11.79 | 10,684 | 125,964 | 203,954 | 214.6 K to 204 K (-4.98 %) |
| Mar 16 2020 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 91,733 | 0 | 214,638 | 122.9 K to 214.6 K (+74.64 %) |
| Dec 05 2019 | NGM | NGM BIOPHARMACEUTI ... | Guyer Shelly D | Director | Option Exercise | A | 17.24 | 48,355 | 833,640 | 48,355 | |
| Aug 21 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 25.29 | 20,447 | 517,193 | 122,905 | 143.4 K to 122.9 K (-14.26 %) |
| Aug 21 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 25.85 | 4,000 | 103,382 | 143,352 | 147.4 K to 143.4 K (-2.71 %) |
| May 22 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 18.21 | 5,513 | 100,392 | 147,352 | 152.9 K to 147.4 K (-3.61 %) |
| May 22 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 17.79 | 4,000 | 71,148 | 152,865 | 156.9 K to 152.9 K (-2.55 %) |
| Mar 01 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 20.52 | 593 | 12,168 | 156,865 | 157.5 K to 156.9 K (-0.38 %) |
| Mar 01 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 19.91 | 3,407 | 67,850 | 157,458 | 160.9 K to 157.5 K (-2.12 %) |
| Jan 18 2019 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 14.49 | 4,000 | 57,968 | 160,865 | 164.9 K to 160.9 K (-2.43 %) |
| Jun 25 2018 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 125,000 | 0 | 164,865 | 39.9 K to 164.9 K (+313.56 %) |
| May 16 2018 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Sell | S | 6.96 | 5,135 | 35,740 | 39,865 | 45 K to 39.9 K (-11.41 %) |
| Jun 13 2017 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Option Exercise | A | 9.18 | 100,000 | 918,000 | 100,000 | |
| Jun 13 2017 | NVTA | Invitae Corp | Guyer Shelly D | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 45,000 | 0 to 45 K |
| Mar 03 2016 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Option Exercise | A | 6.45 | 50,000 | 322,500 | 50,000 | |
| Jul 28 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Option Exercise | M | 6.04 | 1,000 | 6,040 | 146,750 | |
| Jul 28 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Sell | S | 12.47 | 1,000 | 12,470 | 0 | 1,000 to 0 (-100.00 %) |
| Jul 28 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Buy | M | 6.04 | 1,000 | 6,040 | 1,000 | 0 to 1,000 |
| Jun 30 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Option Exercise | M | 6.04 | 1,000 | 6,040 | 147,750 | |
| Jun 30 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Sell | S | 12.08 | 1,000 | 12,080 | 0 | 1,000 to 0 (-100.00 %) |
| Jun 30 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Buy | M | 6.04 | 1,000 | 6,040 | 1,000 | 0 to 1,000 |
| Mar 05 2015 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Option Exercise | A | 8.86 | 75,000 | 664,500 | 75,000 | |
| Jun 23 2014 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Option Exercise | M | 6.04 | 1,250 | 7,550 | 148,750 | |
| Jun 23 2014 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Sell | S | 16.04 | 1,250 | 20,050 | 0 | 1.3 K to 0 (-100.00 %) |
| Jun 23 2014 | VCYT | VERACYTE, INC. | Guyer Shelly D | Chief Financial Off ... | Buy | M | 6.04 | 1,250 | 7,550 | 1,250 | 0 to 1.3 K |
Page: 1